A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma

This study is looking at how a drug behaves in the body (pharmacokinetics) — including how it is absorbed, distributed, and eliminated — as well as its safety and effectiveness in a specific patient population. The focus is on ensuring the right dose is given to the right patients. **You may be eligible if...** - You have the specific condition this drug is being tested for - You meet the age and health requirements of the study - You have not received treatments that would interfere with results - You are willing to provide blood samples at specified time points **You may NOT be eligible if...** - You have significant liver or kidney impairment that could affect how the drug is processed - You take medications that strongly interact with the study drug - You are pregnant or breastfeeding - You have a history of severe allergic reactions to similar drugs Talk to your doctor to see if this trial is right for you.